Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Salvacion R. Gatchalian"'
Autor:
Kristy O. Murray, Nina T. Castillo-Carandang, Anna M. Mandalakas, Andrea T. Cruz, Lauren M. Leining, Salvacion R. Gatchalian
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 10, Pp 1884-1892 (2019)
In 2013, a severe earthquake and typhoon affected Bohol, Philippines. To assess the postdisaster risk for emergence of Mycobacterium tuberculosis infection in children, we conducted a cross-sectional multistage cluster study to estimate the prevalenc
Externí odkaz:
https://doaj.org/article/16d64a35ef9f45f9b2912512f9c17f9f
Autor:
Salvacion R. Gatchalian, Nina T. Castillo-Carandang, Kristy O. Murray, Anna M. Mandalakas, Sarah M. Gunter, Nickolas T. Agathis
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Identifying children with, or at substantial risk of, Mycobacterium tuberculosis infection (TBI) and providing TB preventive therapy (TPT) represent an important, yet challenging, strategy in curbing the global burden of childhood TB. Risk assessment
Autor:
Maria Rosario Z, Capeding, Salvacion R, Gatchalian, Mitzi, Aseron, Anna Lena L, Lopez, Delia C, Yu, Maria E, Garcia Ibe, Maria Nerissa, De Leon, Margaret, Modequillo, Mervin Edcel E, Flavier, Anna Lisa, Ong-Lim
This study aimed to assess the safety of a fully liquid DTwP-HBV/Hib pentavalent vaccine (EupentaTM) based on the occurrence of adverse events (AEs) following vaccination. This was a prospective, open-label, single-arm, interventional phase IV study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89e31eafaac5e1cefcd268f72e29917d
Autor:
Charissa Fay Corazon B. Tabora, Birgit Thierry-Carstensen, Lulu Bravo, Josefina Carlos, Mie Vestergaard Kusk, Ananda S Bandyopadhyay, Salvacion R. Gatchalian, Charlotte Sørensen, Pernille Ingemann Nielsen, May Montellano, Henrik Wachmann, Pernille N. Tingskov
Publikováno v:
Vaccine
Background A dose-sparing inactivated polio vaccine (IPV-Al), obtained by adsorption of inactivated virus to an aluminium hydroxide adjuvant, can help mitigate global supply and the cost constraints of IPV. The objective of this trial was to demonstr
Autor:
Javier Arístegui, S. Riedemann, Khin Maung Win, Vytautas Usonis, Hoosen M. Coovadia, Salvacion R. Gatchalian, Hans L. Bock
Publikováno v:
International Journal of Infectious Diseases. 7(2):143-151
Background: Vaccines are important weapons in the fight against infectious diseases. The World Health Organization (WHO) Expanded Program on Immunization (EPI) has been extended to include recommendations for hepatitis B and Haemophilus influenzae ty
Publikováno v:
The Southeast Asian journal of tropical medicine and public health. 40(5)
The Philippines annual birth cohort of over 2 million is the second largest in the Western Pacific Region; 44% of births occur outside health facilities. With third dose infant hepatitis B (HB) vaccine coverage of 43% in 2006, erratic vaccine supply,
Autor:
Veerachai Watanaveeradej, Pope Kosalaraksa, Yanee Hutagalung, Pensri Kosuwon, H.H. Han, Angkool Kerdpanich, Kurt Dobbelaere, Salvacion R. Gatchalian, Dominique Boutriau, Boonyarat Warachit, Thitiporn Borkird
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 12(1)
SummaryObjectiveSafety and reactogenicity of a new heptavalent DTPw–HBV/Hib–MenAC (diphtheria, tetanus, whole cell pertussis–hepatitis B virus/Haemophilus influenzae type b–Neisseria meningitidis serogroups A and C) vaccine was compared with